These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 4948617)
1. [Value of diagnosis by immunofluorescence in internal medicine]. Salmon J Rev Med Liege; 1971 Oct; 26(20):687-9. PubMed ID: 4948617 [No Abstract] [Full Text] [Related]
2. SLE: the value of immunological tests and aspects of management. Edmonds JP Aust N Z J Med; 1978; 8 Suppl 1():116-23. PubMed ID: 365157 [No Abstract] [Full Text] [Related]
3. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases. Deodhar SD Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749 [TBL] [Abstract][Full Text] [Related]
4. Nuclear immunofluorescence: a guide to treatment in S.L.E. Mandl MA; Watson JI Lancet; 1969 Oct; 2(7625):848. PubMed ID: 4186304 [No Abstract] [Full Text] [Related]
5. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN; Joller-Jemelka HI; Grob PJ Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
6. Skin immunofluorescence patterns in SLE patients in Singapore. Ratnam KV; Phay KL; Ng SK; Tan T Singapore Med J; 1987 Dec; 28(6):517-9. PubMed ID: 3327168 [No Abstract] [Full Text] [Related]
7. Diagnosis of systemic lupus erythematosus and lupus nephritis. Roberts JL Contrib Nephrol; 1983; 35():150-69. PubMed ID: 6339160 [No Abstract] [Full Text] [Related]
8. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus]. Chorzelski T; Blaszczyk M Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588 [No Abstract] [Full Text] [Related]
9. Serum complement related to skin lesions of systemic lupus erythematosus. Marshall DA; Nesbitt LT; Biundo JJ South Med J; 1974 Nov; 67(11):1275-9. PubMed ID: 4139764 [No Abstract] [Full Text] [Related]
10. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence. Burnham TK; Neblett TR; Fine G; Bank P Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089 [No Abstract] [Full Text] [Related]
11. [Systemic lupus erythematosus (SLE). I. New insights into serology and pathogenesis]. Feltkamp TE Ned Tijdschr Geneeskd; 1974 Feb; 118(5):166-70. PubMed ID: 4596539 [No Abstract] [Full Text] [Related]
12. [Immunofluorescence in internal medicine]. Storch W Z Gesamte Inn Med; 1972 Dec; 27(24):1061-7. PubMed ID: 4569866 [No Abstract] [Full Text] [Related]
14. Immunoglobulins in the larynx in systemic lupus erythematosus. Gilliam JN; Cheatum DE Arch Dermatol; 1973 Nov; 108(5):696-7. PubMed ID: 4127210 [No Abstract] [Full Text] [Related]
15. [The role of immunofluorescence methods in dermatology (technic and clinical use)]. Barthelmes H; Sönnichsen N Dermatol Monatsschr; 1970; 156(3):184-211. PubMed ID: 4934301 [No Abstract] [Full Text] [Related]
16. The gammaG subclass of antinuclear and antinucleic acid antibodies. Schur PH; Monroe M; Rothfield N Arthritis Rheum; 1972; 15(2):174-82. PubMed ID: 4554890 [No Abstract] [Full Text] [Related]
17. [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus]. Kostadinova DA; Razboĭnikov S Vutr Boles; 1976; 15(2):18-26. PubMed ID: 59467 [No Abstract] [Full Text] [Related]
18. Auto-antibodies of the IgD class. Kantor GL; Van Herle AJ; Barnett EV Clin Exp Immunol; 1970 Jun; 6(6):951-62. PubMed ID: 4920553 [TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies and complement in rheumatic diseases. Maini RN Rep Rheum Dis; 1977 Jan; (60):1-4. PubMed ID: 64996 [No Abstract] [Full Text] [Related]
20. [Lupus-erythematosus-like syndromes]. Haustein UF Z Gesamte Inn Med; 1977 May; 32(10):218-21. PubMed ID: 303027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]